CIMINO, SEBASTIANO
 Distribuzione geografica
Continente #
NA - Nord America 4.904
AS - Asia 2.478
EU - Europa 1.707
SA - Sud America 478
AF - Africa 343
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
Totale 9.918
Nazione #
US - Stati Uniti d'America 4.735
SG - Singapore 1.379
CN - Cina 739
IE - Irlanda 460
BR - Brasile 401
IT - Italia 396
UA - Ucraina 307
CI - Costa d'Avorio 263
RU - Federazione Russa 240
CA - Canada 143
VN - Vietnam 138
KR - Corea 56
DE - Germania 55
GB - Regno Unito 51
FR - Francia 45
IN - India 44
AR - Argentina 42
SE - Svezia 37
SN - Senegal 31
PL - Polonia 28
ES - Italia 20
HK - Hong Kong 20
BD - Bangladesh 19
MX - Messico 19
TR - Turchia 15
CH - Svizzera 14
FI - Finlandia 13
ZA - Sudafrica 13
NL - Olanda 12
PK - Pakistan 11
BJ - Benin 10
UZ - Uzbekistan 10
ID - Indonesia 9
IQ - Iraq 9
EC - Ecuador 7
JP - Giappone 7
CL - Cile 6
CO - Colombia 6
EG - Egitto 6
MA - Marocco 6
NG - Nigeria 6
PY - Paraguay 6
VE - Venezuela 6
BE - Belgio 5
EU - Europa 5
GR - Grecia 5
SA - Arabia Saudita 5
AT - Austria 4
AU - Australia 3
BG - Bulgaria 3
IR - Iran 3
KE - Kenya 3
TN - Tunisia 3
UY - Uruguay 3
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
IL - Israele 2
JM - Giamaica 2
LB - Libano 2
LT - Lituania 2
NO - Norvegia 2
OM - Oman 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
DZ - Algeria 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MD - Moldavia 1
PH - Filippine 1
RO - Romania 1
SI - Slovenia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
Totale 9.918
Città #
Dallas 866
Santa Clara 835
Singapore 727
Dublin 458
Chandler 455
Jacksonville 426
Abidjan 262
Boardman 202
Chicago 183
Ashburn 141
Hefei 132
Cambridge 126
Catania 126
Nanjing 126
Lawrence 125
Andover 123
Toronto 104
Beijing 99
Los Angeles 86
Des Moines 77
Moscow 67
Seoul 56
Wilmington 53
São Paulo 43
San Mateo 38
Civitanova Marche 37
Hanoi 36
Hebei 36
Nanchang 34
Ho Chi Minh City 33
Shenyang 33
New York 32
Dakar 31
Milan 29
Saint Petersburg 29
Buffalo 26
Council Bluffs 26
Jiaxing 26
The Dalles 26
Dong Ket 25
Ottawa 24
Bremen 23
Columbus 22
Tianjin 22
Warsaw 21
Hong Kong 20
Houston 17
Changsha 16
Padova 15
Rome 15
Kochi 14
Rio de Janeiro 14
London 13
Belo Horizonte 12
Brooklyn 12
Seattle 12
Norwalk 11
San Francisco 11
Cotonou 10
Denver 10
Falls Church 10
Jinan 10
Phoenix 10
Redondo Beach 10
Curitiba 9
Munich 9
Pune 9
Kunming 8
Zhengzhou 8
Ann Arbor 7
Atlanta 7
Boston 7
Chennai 7
Den Haag 7
Johannesburg 7
Mexico City 7
Tokyo 7
Washington 7
Abuja 6
Brasília 6
Campinas 6
Helsinki 6
Mascalucia 6
Montreal 6
Osasco 6
Paternò 6
Porto Alegre 6
Brussels 5
Campo Grande 5
Charlotte 5
Dhaka 5
Goiânia 5
Haiphong 5
Hangzhou 5
Lappeenranta 5
Manchester 5
Mountain View 5
Shanghai 5
São Gonçalo 5
Amsterdam 4
Totale 6.973
Nome #
Age Is an Independent Predictive Factor of Erectile Dysfunction after TURP in Potent Patients PDE5-Inhibitors Naïve 141
Accuracy capabilities comparisons between Karakiewicz, Kattan and Cindolo nomograms in predicting outcomes for renal cancer carcinoma: A systematic review and meta-analysis. 126
Active surveillance for low-risk prostate cancer: are all criteria similar? 126
A case of gross haematuria due to an ureteric-iliac artery fistula 125
Alga Ecklonia bicyclis, Tribulus terrestris, and Glucosamine Oligosaccharide Improve Erectile Function, Sexual Quality of Life, and Ejaculation Function in Patients with Moderate Mild-Moderate Erectile Dysfunction: A Prospective, Randomized, Placebo-Controlled, Single-Blinded Study 120
A phase II, randomized, single-blinded, placebo-controlled clinical trial on the efficacy of curcumina and calendula suppositories for the treatment of patients with chronic prostatitis/chronic pelvic pain syndrome type III 114
Association between dietary phytoestrogens intakes and prostate cancer risk in Sicily 114
Markers of semen inflammation: supplementary semen analysis? 114
A Systematic Review and Meta-analysis of the Diagnostic Accuracy of Prostate Health Index and 4-Kallikrein Panel Score in Predicting Overall and High-grade Prostate Cancer 113
Benign prostatic hyperplasia, metabolic syndrome and non-alcoholic fatty liver disease: is metaflammation the link? 110
High rate of detection of ultrasound signs of prostatitis in patients with HPV-DNA persistence on semen: role of ultrasound in HPV-related male accessory gland infection 110
Association between dietary flavonoids intake and prostate cancer risk: A case-control study in Sicily 109
Adherence to Mediterranean diet and prostate cancer risk in Sicily: population-based case–control study 109
Confirmatory biopsy of men under active surveillance: extended versus saturation versus multiparametric magnetic resonance imaging/transrectal ultrasound fusion prostate biopsy 103
Benign prostatic hyperplasia and intraprostatic inflammation are associated with liver inflammation: it's time for prevention 103
Correlation between lipid profile and heme oxygenase system in patients with benign prostatic hyperplasia 101
Impact of anabolic androgenic steroids on male sexual and reproductive function: a systematic review 100
Oxidative stress and body composition in prostate cancer and benign prostatic hyperplasia patients 97
Adherence to Healthy or Unhealthy Pro-Vegetarian Plant-Based Diets Have Different Impact on Prostate Cancer Severity: Preliminary Findings 95
Increase of Framingham cardiovascular disease risk score is associated with severity of lower urinary tract symptoms 94
Metabolic syndrome is not associated with greater evidences of proliferative inflammatory atrophy and inflammation in patients with suspected prostate cancer 94
Effects of Serenoa repens, selenium and lycopene (Profluss®) on chronic inflammation associated with benign prostatic hyperplasia: results of "FLOG" (Flogosis and Profluss in Prostatic and Genital Disease), a multicentre Italian study 92
Beneficial Effects of the Very-Low-Calorie Ketogenic Diet on the Symptoms of Male Accessory Gland Inflammation 92
PD-1, PD-L1 and cAMP immunohistochemical expressions are associated with worse oncological outcome in patients with bladder cancer 91
1472 evaluation of extra cellular signal-reguladed kinases ½ (ERK1/2), epidermal growth factor receptor (EGFR) and P53 protein as biomarkers of cancer progression in bladder cancer 90
Conversion to Sirolimus Therapy in Kidney Transplant Recipients with New Onset Diabetes Mellitus after Transplantation 90
Evaluation of intralesional injection of hyaluronic acid compared with verapamil in Peyronie's disease: preliminary results from a prospective, double-blinded, randomized study 89
Association between metabolic syndrome and intravesical prostatic protrusion in patients with benign prostatic enlargement and lower urinary tract symptoms (MIPS Study) 89
Delayed graft function and long-term outcome in kidney transplantation 87
Dietary Consumption of Phenolic Acids and Prostate Cancer: A Case-Control Study in Sicily, Southern Italy. 87
Determinants of sexual impairment in multiple sclerosis in male and female patients with lower urinary tract dysfunction: results from an italian cross-sectional study. 84
ASSOCIAZIONE TRA LA STEATOSI EPATICA NON ALCOLICA E I SINTOMI DEL BASSO TRATTO URINARIO: RISULTATI DI UNO STUDIO TRASVERSALE 84
Prostatic Arterial Embolization vs Open Prostatectomy: A 1-Year Matched-pair Analysis of Functional Outcomes and Morbidities. 83
“Aquabeam® System” for benign prostatic hyperplasia and LUTS: birth of a new era. A systematic review of functional and sexual outcome and adverse events of the technique 83
Emerging links between non-neurogenic lower urinary tract symptoms secondary to benign prostatic obstruction, metabolic syndrome and its components: A systematic review 82
Pharmacotherapeutic management of lower urinary tract symptoms in Multiple Sclerosis Patients 82
64CuCl2PET/CT as a potential new imaging method in prostate cancer: Illusion or reality? 81
PHI and PCA3 improve the prognostic performance of PRIAS and Epstein criteria in predicting insignificant prostate cancer in men eligible for active surveillance. 80
VALUTAZIONE PREDITTIVA DI DISFUNZIONE ERETTILE IN PAZIENTI SESSUALMENTE ATTIVI ALLA PRIMA VISITA UROLOGICA: NUOVO TOOL PER LA STRATIFICAZIONE DEL RISCHIO 80
Association between long-term erectile dysfunction and biochemical recurrence after permanent seed I-125 implant brachytherapy for prostate cancer. A longitudinal study of a single-institution 79
Role of multiparametric magnetic resonance imaging for patients under active surveillance for prostate cancer: a systematic review with diagnostic meta-analysis 79
Different levels of Cd45pos leukocytes in the semen of patients with low testicular volume 78
Relationship between non-alcoholic fatty liver disease and benign prostatic hyperplasia/lower urinary tract symptoms: new insights from an Italian cross-sectional study 78
Association Between the Neurogenic Bladder Symptom Score and Urodynamic Examination in Multiple Sclerosis Patients With Lower Urinary Tract Dysfunction 77
Complication Rate After Antibiotic Prophylaxis with Fosfomycin Versus Fluorochinolones or β-lactam Antibiotics in Patients Undergoing Prostate Biopsy: A Propensity Score-adjusted Analysis 76
Benign prostatic hyperplasia and metabolic syndrome: the expanding evidences of a new disease of aging male. 76
Predicting erectile dysfunction in sexually active patients seeking prostate health screening: proposal for a multivariable risk stratification 76
Expression of CD7, CD20 and CDX-2 in a secondary signet-ring cell tumor of the prostate: a case report. 76
The gonadal function in obese adolescents: review 75
Metabolic syndrome and prostatic disease: potentially role of polyphenols in preventive strategies. A review 75
Predictive factors of erectile dysfunction after TURP in potent patients 75
Nutraceutici attivi in Urologia” Nutraceutici ed alimenti funzionali in medicina preventiva 75
Comparison of perioperative and short-terms outcomes of en-bloc Holmium laser enucleation of the prostate (HoLEP) and robot-assisted simple prostatectomy: a propensity-score matching analysis 74
The semen quality of the mobile phone users 74
Serenoa Repens, Lycopene and Selenium Versus Tamsulosin for the Treatment of LUTS/BPH. An Italian Multicenter Double-Blinded Randomized Study Between Single or Combination Therapy (PROCOMB Trial) 73
The Concept of Self and Emotional Involvement in Living Kidney Donation: A Psychometric Investigation 73
Transurethral resection of the prostate (TURP) vs GreenLight photoselective vaporization of benign prostatic hyperplasia: analysis of BPH6 outcomes after 1 year of follow-up 72
Clinical and psychological outcomes of patients undergoing Retrograde Intrarenal Surgery and Miniaturised Percutaneous Nephrolithotomy for kidney stones. A preliminary study 72
Pneumatic lithotripsy versus holmium: YAG laser lithotripsy in the management of ureteral stones 71
Risk factors of sexual dysfunction after transurethral resection of the prostate (TURP): A 12months follow-up 71
Prevalence of Intratubular Germ Cell Neoplasia and Multifocality in Testicular Germ Cell Tumors ≤ 2 cm: Relationship With Other Pathological Features 71
Chromophobe renal cell carcinoma (RCC): Oncological outcomes and prognostic factors in a large multicentre series 71
Dietary patterns and prostatic diseases. 70
Intratumoral Heterogeneity Determines the Expression of mTOR-pathway Proteins in Prostate Cancer 70
Combination of Intralesional Verapamil and Oral PeironiMEV-plus® for Peyronie’s Disease: A Prospective, Randomized Study 70
Reduced seminal concentration of CD45pos cells after follicle-stimulating hormone treatment in selected patients with idiopatic oligoasthenoteratozoospermia 70
Neutrophil to lymphocyte ratio, a biomarker in non-muscle invasive bladder cancer: a single-institutional longitudinal study. 69
Consulting “Dr Google” for sexual dysfunction: a contemporary worldwide trend analysis 69
Effects of detrusorial overactivity and disability on sexual function in multiple sclerosis patients: analysis from a single centre cross sectional study 68
Combination of Intralesional Verapamil and Oral Antioxidants for Peyronie’s Disease: a prospective, randomized-controlled study 68
Microbiological investigation in male infertility: a practical overview 68
Polyphenols: Key Issues Involved in Chemoprevention of Prostate Cancer 68
Extracorporeal Shock Wave Therapy in Peyronie's Disease: Clinical Efficacy and Safety from a Single-Arm Observational Study 68
Use of alpha(1)-blockers in female functional bladder neck obstruction 67
Pneumatic Lithotripsy versus Holmium:YAG Laser Lithotripsy for the Treatment of Single Ureteral Stones: A Prospective, Single-Blinded Study 67
Prognostic accuracy of Prostate Health Index and urinary Prostate Cancer Antigen 3 in predicting pathologic features after radical prostatectomy. 67
Tailored treatment including radical prostatectomy and radiation therapy + androgen deprivation therapy versus exclusive radical prostatectomy in high-risk prostate cancer patients: results from a prospective study 67
Performance of biopsy factors in predicting unfavorable disease in patients eligible for active surveillance according to the PRIAS criteria 67
Endothelial progenitor cells and erectile dysfunction: a brief review on the diagnostic significance and summary of our experience 66
NON-ALCOHOLIC FATTY LIVER DISEASE IS ASSOCIATED WITH GREATER SEVERITY OF INTRA PROSTATIC INFLAMMATION IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA 66
Effects of dutasteride on sex hormones and cerebrospinal steroids in patients treated for benign prostatic hyperplasia 66
Evaluation of the “Teaching Guide for Basic Laparoscopic Skills” as a stand-alone educational tool for hands-on training sessions: a pilot study 65
Heme oxygenase-1 prostatic levels are significantly lower in patients affected by moderate-severe LUTS secondary to benign prostatic hyperplasia: A pilot study 64
Impact of the COVID-19 Pandemic on Global Diseases and Human Well-Being 63
Editorial comment to The efficacy of acupuncture in managing patients with chronic prostatitis/chronic pelvic pain syndrome: A systemic review and meta-analysis 63
Vascular regenerative therapies for the treatment of erectile dysfunction: current approaches 63
Functional characterization of platelets in patients with arterial erectile dysfunction 63
Impact of Preoperative Patient Characteristics and Flow Rate on Failure, Early Complications, and Voiding Dysfunction After a Transobturator Tape Procedure: A Multicentre Study 63
Genomic landscape alterations in primary tumor and matched lymph node metastasis in prostate cancer patients 62
Potential efficacy of some african plants in benign prostatic hyperplasia and prostate cancer 62
Heme oxygenase levels and metaflammation in benign prostatic hyperplasia patients 62
Detection rate for significant cancer at confirmatory biopsy in men enrolled in Active Surveillance protocol: 20 cores vs 30 cores vs MRI/TRUS fusion prostate biopsy 62
Adherence to the Mediterranean diet and prostate cancer severity 62
The Clinical Role of SRSF1 Expression in Cancer: A Review of the Current Literature 61
How Can the COVID-19 Pandemic Lead to Positive Changes in Urology Residency? 61
The Role of the Heme Oxygenase System in the Metabolic Syndrome 60
Re: Relationship between lower urinary tract symptoms and serum levels of sex hormones in men with symptomatic benign prostatic hyperplasia 58
CYP7B1 as a Biomarker for Prostate Cancer Risk and Progression: Metabolic and Oncogenic Signatures (Diagnostic Immunohistochemistry Analysis by Tissue Microarray in Prostate Cancer Patients—Diamond Study) 58
Impact of combination therapy 5-alpha reductase inhibitors (5-ARI) plus alpha-blockers (AB) on erectile dysfunction and decrease of libido in patients with LUTS/BPH: a systematic review with meta-analysis 58
Prognostic role of tumour multifocality in renal cell carcinoma. 58
Totale 8.040
Categoria #
all - tutte 38.563
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.563


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021315 0 0 0 0 0 18 92 3 39 24 93 46
2021/2022870 101 136 3 13 141 10 131 26 62 1 29 217
2022/20231.440 141 52 20 132 169 246 4 220 367 22 41 26
2023/2024642 40 147 25 30 11 131 7 42 14 16 108 71
2024/20252.755 46 381 157 93 632 391 80 113 164 331 167 200
2025/20262.857 293 262 1.021 375 854 52 0 0 0 0 0 0
Totale 10.141